"Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions" Available #openaccess here: link.springer.com/article/10.100… #covid19 #infectiousdiseases

"#Safety, #Tolerability, and #Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers" link.springer.com/article/10.100… #RespiratorySyncytialVirus #RSV

How do we define long-COVID for better research, diagnostics and treatment? In this commentary, just published in Infectious Diseases & Therapy, the authors propose refinement into three sub-groups - read more here: link.springer.com/article/10.100…

New research just published in Infectious Diseases and Therapy describes a model which estimated the cost benefits of using the antiviral drug baloxavir, compared to oseltamivir or no treatment for #influenza patients. link.springer.com/article/10.100…

The latest piece of research published in Infectious Diseases and Therapy looked at the extracorporeal removal of cytokines from the bloodstream, and the potential of this therapy to help in treating septic shock. More here: link.springer.com/article/10.100…

Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review: link.springer.com/article/10.100…

Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19: link.springer.com/article/10.100…

Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes link.springer.com/article/10.100…

Influenza-Associated Excess Mortality and Hospitalization in Germany from 1996 to 2018: link.springer.com/article/10.100…

Acute Cerebellitis Following COVID-19: Alarming Clinical Presentation Challenged by Normal Paraclinical Findings: link.springer.com/article/10.100…

Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort Study: link.springer.com/article/10.100…

Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations? link.springer.com/article/10.100…

This study, just published in Infectious Diseases and Therapy, evaluated the value-based price of the RSVpreF vaccine for pregnant people used for prevention of RSV-LRTI among infants in Argentina: link.springer.com/article/10.100…

Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19: link.springer.com/article/10.100…

Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients #COVIDー19 Read the full article #openaccess here: link.springer.com/article/10.100…

COVID-19 Vaccination Recommendations for Immunocompromised Patient Populations: Delphi Panel and Consensus Statement Generation in the United States #COVIDー19 Read the full article #OpenAccess here: link.springer.com/article/10.100…

Our latest review explores the characteristics and uses of endolysins derived from staphylococcal bacteriophages, as well as their antibacterial effectiveness against Staphylococcus spp. Read the full article here: link.springer.com/article/10.100…

Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults. Read the full article here: link.springer.com/article/10.100…

Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis. Read the full article here: link.springer.com/article/10.100…

Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis. Read the full article here: link.springer.com/article/10.100…